314 related articles for article (PubMed ID: 32523310)
1. Treatment of gastrointestinal bleeding in left ventricular assist devices: A comprehensive review.
Vedachalam S; Balasubramanian G; Haas GJ; Krishna SG
World J Gastroenterol; 2020 May; 26(20):2550-2558. PubMed ID: 32523310
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal bleeding in patients with continuous-flow left ventricular assist devices: A comprehensive review.
Del Rio-Pertuz G; Nair N
Artif Organs; 2023 Jan; 47(1):12-23. PubMed ID: 36334280
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular assist devices and gastrointestinal bleeding: a narrative review of case reports and case series.
Islam S; Cevik C; Madonna R; Frandah W; Islam E; Islam S; Nugent K
Clin Cardiol; 2013 Apr; 36(4):190-200. PubMed ID: 23378047
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and Predictors of Readmissions with GI Bleeding in Patients with Left Ventricular Assist Devices.
Shah R; Qayed E
South Med J; 2018 Nov; 111(11):666-673. PubMed ID: 30392001
[TBL] [Abstract][Full Text] [Related]
5. Treatment of left ventricular assist device-associated arteriovenous malformations with thalidomide.
Ray R; Kale PP; Ha R; Banerjee D
ASAIO J; 2014; 60(4):482-3. PubMed ID: 24830804
[TBL] [Abstract][Full Text] [Related]
6. Octreotide for left ventricular assist device-related gastrointestinal hemorrhage: can we stop the bleeding?
Rennyson SL; Shah KB; Tang DG; Kasirajan V; Pedram S; Cahoon W; Malhotra R
ASAIO J; 2013; 59(4):450-1. PubMed ID: 23820288
[TBL] [Abstract][Full Text] [Related]
7. Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in Patients With Left Ventricular Assist Devices.
Converse MP; Sobhanian M; Taber DJ; Houston BA; Meadows HB; Uber WE
J Am Coll Cardiol; 2019 Apr; 73(14):1769-1778. PubMed ID: 30975293
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal Bleeding Following LVAD Placement from Top to Bottom.
Cushing K; Kushnir V
Dig Dis Sci; 2016 Jun; 61(6):1440-7. PubMed ID: 27017225
[TBL] [Abstract][Full Text] [Related]
9. Association of Nasal Mucosal Vascular Alterations, Gastrointestinal Arteriovenous Malformations, and Bleeding in Patients With Continuous-Flow Left Ventricular Assist Devices.
Patel SR; Madan S; Saeed O; Algodi M; Luke A; Gibber M; Goldstein DJ; Jorde UP
JACC Heart Fail; 2016 Dec; 4(12):962-970. PubMed ID: 27744088
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide Use Reduces Risk of Refractory Gastrointestinal Bleeding in Patients with Continuous Flow Left Ventricular Assist Devices.
Namdaran P; Zikos TA; Pan JY; Banerjee D
ASAIO J; 2020 Jun; 66(6):645-651. PubMed ID: 31425265
[TBL] [Abstract][Full Text] [Related]
11. Octreotide in the management of recurrent gastrointestinal bleed in patients supported by continuous flow left ventricular assist devices.
Loyaga-Rendon RY; Hashim T; Tallaj JA; Acharya D; Holman W; Kirklin J; Pamboukian SV
ASAIO J; 2015; 61(1):107-9. PubMed ID: 25232774
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II antagonists and gastrointestinal bleeding in left ventricular assist devices: A systematic review and meta-analysis.
Kittipibul V; Vutthikraivit W; Kewcharoen J; Rattanawong P; Tantrachoti P; Putthapiban P; Nair N
Int J Artif Organs; 2021 Mar; 44(3):215-220. PubMed ID: 32842844
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal Bleeding in Left Ventricular Assist Device: Octreotide and Other Treatment Modalities.
Molina TL; Krisl JC; Donahue KR; Varnado S
ASAIO J; 2018; 64(4):433-439. PubMed ID: 29406356
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices.
Houston BA; Schneider AL; Vaishnav J; Cromwell DM; Miller PE; Faridi KF; Shah A; Sciortino C; Whitman G; Tedford RJ; Stevens GR; Judge DP; Russell SD; Rouf R
J Heart Lung Transplant; 2017 Apr; 36(4):380-385. PubMed ID: 28169115
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal bleeding with continuous-flow left ventricular assist devices.
Amer S; Shah P; Hassan S
Clin J Gastroenterol; 2015 Apr; 8(2):63-7. PubMed ID: 25614135
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal bleeding after continuous-flow left ventricular device implantation: review of pathophysiology and management.
Guha A; Eshelbrenner CL; Richards DM; Monsour HP
Methodist Debakey Cardiovasc J; 2015; 11(1):24-7. PubMed ID: 25793026
[TBL] [Abstract][Full Text] [Related]
17. Bleeding with the artificial heart: Gastrointestinal hemorrhage in CF-LVAD patients.
Gurvits GE; Fradkov E
World J Gastroenterol; 2017 Jun; 23(22):3945-3953. PubMed ID: 28652649
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal Bleeding in Patients Supported with Left Ventricular Assist Devices: The Journey from Bridging to Destination.
Mohamed MS; Shehadah A; Hashem A; Chand S; Bapaye J; Khalouf A; Rai D; Peter S
Am J Cardiol; 2023 Aug; 201():71-77. PubMed ID: 37352668
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapeutic Management of Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices.
Sieg AC; Moretz JD; Horn E; Jennings DL
Pharmacotherapy; 2017 Nov; 37(11):1432-1448. PubMed ID: 28833332
[TBL] [Abstract][Full Text] [Related]
20. Novel Use of Thalidomide in Recurrent Gastrointestinal Tract Bleeding in Patients with Left Ventricular Assist Devices: A Case Series.
Chan LL; Lim CP; Lim CH; Tan TE; Sim D; Sivathasan C
Heart Lung Circ; 2017 Oct; 26(10):1101-1104. PubMed ID: 28131776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
